For patients, medical innovation is not an abstract policy debate. It is more time, better treatment, less suffering, and a real chance at a longer, healthier life. That is the...
As the House Energy and Commerce Health Subcommittee meets on March 18, 2026, at 10:15 a.m. ET for the third hearing in its health care affordability series, lawmakers should look...
During his February 24 State of the Union address, President Trump took a victory lap on prescription drug prices. He touted “most favored nation” pricing, highlighted the TrumpRx website, and...
Over the last two decades, we have witnessed something genuinely unusual in public health: a medical breakthrough that has rapidly moved from specialist clinics into everyday conversation. GLP-1 drugs such...
At first glance, the 340B program sounds simple. Certain hospitals and clinics can buy medicines at much lower prices. The idea is that these lower prices help them support patients...
TrumpRx Pretends to Fix Drug Prices When The Market Already Did WASHINGTON, D.C. — Last night, the Trump Administration rolled out a new website, TrumpRx.gov, to facilitate direct-to-consumer (DTC) drug...
The launch of TrumpRx has been framed as a breakthrough moment in lowering U.S. drug prices. The website promises to find “the world’s lowest prices” on prescription medicines and applies...
When it comes to medical tech and innovation, the United States remains the global leader in a new study by the Foundation for Research on Equal Opportunity (FREOPP). American leadership in cancer...
When it comes to medical tech and innovation, the United States is the global leader. A 2024 study by the Foundation for Research on Equal Opportunity (FREOPP) showed that American leadership...
The Consumer Choice Center mourns the passing of Dan Grossman. We are deeply saddened by the passing of our board member, mentor, friend, Dan Grossman. Dan was a kind and...
Berlin (ots) – Wenn im Dezember die Innenstädte funkeln, Glühweinstände öffnen und die Menschen durch die Fußgängerzonen drängen, dann wird jedes Jahr aufs Neue deutlich, wie sehr Konsum, Alltag und...
Good news: Obesity rates are going down thanks to novel anti-obesity treatments around GLP-1 agonists. Diabetes Type 2 can be combatted. How can current manufacturing bottlenecks and access barriers for...
